Ciprobay Tablet 250 mg. 500 mg. 750 mg FC Tablets
PDF Leaflet Revision Date: 14 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Severe and/or complicated infections caused by ciprofloxacin-sensitive bacteria.
Dosage (summary)
250-750 mg twice daily; 750 mg for severe infections.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding due to potential fetal harm.
Key Drug Interactions
- QT prolonging agents
- Tizanidine
- Theophylline
- Methotrexate
Contraindications
- Hypersensitivity to ciprofloxacin
- Pregnancy
- Lactation
- Myasthenia gravis
Common side effects
- Nausea
- Diarrhoea
- Headache
- Tendonitis
- Photosensitivity
Counselling Points
- Stay hydrated to prevent crystalluria
- Avoid dairy products during administration
- Monitor for signs of tendon pain or swelling
Serious warnings
- Risk of tendon rupture
- QT prolongation
- Severe skin reactions
Important Disclaimer
The Ciprobay Tablet 250 mg. 500 mg. 750 mg FC Tablets professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
